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Diphenyl diselenide ([PhSe]2)is an organoselenium compound that has interesting pharmacological
properties, including antioxidant, glutathione peroxidase-mimetic, and neuroprotective effects. The
objective of the present study was to investigate the possible modulatory effect of (PhSe)2 in 17th-
generation Carioca high-and low-conditioned freezing (CHF and CLF) rats, an animal model of general-
ized anxiety disorders. (PhSe)2 was administered at three doses (10, 50, and 100 mg/kg) in CHF and CLF
rats, and their anxiety-like proﬁles (conditioned freezing patterns) were measured before and 30 min
after treatment. A signiﬁcant difference was found in freezing scores between CHF and CLF animals
before treatment (t70¼12.50, po0.001). Treatment with (PhSe)2 at 10 and 50 mg/kg decreased freezing
in CHF rats but signiﬁcantly increased freezing at 100 mg/kg. (PhSe)2 increased freezing in CLF animals at
50 and 100 mg/kg (po0.01). These results indicate that (PhSe)2 exerts both anxiolytic- and anxiogenic-
like effects in bi-directional rat lines. Distinct genetic proﬁles of the CHF and CLF lines may inﬂuence
biochemical functions and lead to differential responses to aversive situations and various drugs like
(PhSe)2.
& 2015 Elsevier B.V. All rights reserved.1. Introduction
We recently demonstrated an association between oxidative
stress and the genesis of anxiety using a novel rat breeding line
known as Carioca High‐and Low‐Conditioned Freezing (CHF and
CLF; Hassan et al., 2013). The breeding protocol for these animals is
based on defensive freezing responses to contextual cues that are
associated with electric footshock (Dias et al., 2009; Castro-Gomes
and Landeira-Fernandez, 2008). The anxiety-like proﬁle of these
animals was conﬁrmed with several behavioral test protocols
(Hassan et al., 2013; Dias et al., 2009; Castro-Gomes and Landeira-
Fernandez, 2008). The levels of reactive species (RS) and rate of
lipid peroxidation (LPO) were higher in CHF rats than in CLF rats.
Consequently, low antioxidant enzymatic status was conﬁrmed in
CHF animals, reﬂected by glutathione peroxidase (GPx) and cata-
lase (CAT) activity in various brain structures, including the cortex,
hippocampus, and cerebellum (Hassan et al., 2013). These resultsComportamental, Departa-
do Rio de Janeiro, Rua Mar-
o, RJ 22453-900, Brazil.
ernandez).are consistent with other studies that reported the direct in-
volvement of oxidative stress in anxiety-related disorders (Salim,
2011). Oxidative stress has been linked to the pathological mani-
festations of other psychological and neurological disorders (An-
dersen, 2004).
The use of antioxidants may be beneﬁcial for ameliorating the
adverse effects of oxidative bursts and may help reduce anxiety.
Various dietary and synthetic antioxidants have been reported to
protect against anxiety-related disorders (Salim, 2011; Bouayed
and Kalinin, 2011; Augustyniak et al., 2010). Vitamin C, rutin,
caffeic acid, and rosmarinic acid have been reported to have an-
tidepressant and anxiolytic effects at lower doses (Atmaca et al.,
2004). Masood et al. (2008) recently showed that supplementation
with tempol (an antoxidant) reduced buthionine-[S,R]-sulfoximine
(BSO)-induced anxiety-like behavior in rats. Importantly, BSO
produces oxidative stress by inhibiting glutathione (GSH)
synthesis.
Data regarding synthetic antioxidants are very diverse, and a
range of different classes have been reported in the literature
(Augustyniak et al., 2010). Organoselenium compounds have
gained increasing attention because of their broad applications in
organic synthesis and pharmacological efﬁcacy. Various classes of
selenium compounds have been shown to have interesting
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peroxidation, radical-scavenging, antiinﬂammatory, anti-
nociceptive, cardioprotective, and thioredoxin reductase activity
(Nogueira et al., 2004). Diphenyl diselenide ([PhSe]2), the simplest
diaryl diselenide, has shown remarkable potential in various ani-
mal models of pathology (Nogueira and Rocha, 2010). Interest-
ingly, selenium deﬁciency has been related to depression, mood
disorders, and anxiety (Sher, 2000; 2007; Rayman, 2000).Sele-
nium supplementation has been shown to improve both anxious
and depressive symptoms (Benton, 2002; Benton and Cook, 1991).
Different mono- and diselenides have been used in various models
of anxiety and depression. Depending on the chemical structure,
route of administration, and dose, various compounds have shown
promising antidepressant and anxiolytic activities (Nogueira and
Rocha, 2011).
To our knowledge, no study has focused on the possible mod-
ulatory effects of (PhSe)2in bi-directional rat lines. With distinct
and speciﬁc neurochemical and neurogenetic proﬁles, bi-direc-
tional lines are important for exploring the underlying mechan-
isms of anxiety-related behavior. In the present study, 17th-gen-
eration CHF and CLF rats were treated with different doses of
(PhSe)2 to gain a better understanding of the possible psycho-
modulatory effects of this organoselenium compound.2. Material and methods
2.1. Animals
The present study used rats that were selectively bred for high
(CHF) and low (CLF) contextual fear conditioning according to
procedures described in our previous work (Castro-Gomes and
Landeira-Fernandez, 2008). Female albino Wistar rats from the
17th generation of selective breeding were 15–20 weeks old and
weighed 180–300 g at the beginning of the study. They were bred
and maintained in the colony room in the Psychology Department
of the Pontifícia Universidade Católica do Rio de Janeiro with
controlled room temperature (2471 °C) and a 12 h/12 h light/dark
cycle (lights on 7:00 AM–7:00 PM). The animals were housed in
groups of three to ﬁve, according to their respective lines, in
polycarbonate cages (183138 cm3) with food and water
available ad libitum. All of the behavioral experiments were con-
ducted during the light phase of the light/dark cycle. The animals
were handled once daily for a period of 2 min for 5 days before the
fear conditioning experiment. The experimental procedures re-
ported herein were performed in accordance with the guidelines
for experimental animal research established by the Brazilian So-
ciety of Neuroscience and Behavior (SBNeC) and the National In-
stitutes of Health Guide for the Care and Use of Laboratory Ani-
mals. Animal handling and the methods of sacriﬁce were reviewed
and approved by the Committee for Animal Care and Use of PUC-
Rio (protocol no. 20/2009).
2.2. Chemicals
(PhSe)2 was prepared in our laboratory according to a previous
report (Paulmier, 1986). Analysis of the 1H nuclear magnetic re-
sonance (NMR) and 13C NMR spectra showed that (PhSe)2 pre-
sented analytical and spectroscopic data in full agreement with its
assigned structure. The chemical purity of the compound (99.9%)
was determined by gas chromatography/high-performance liquid
chromatography and was stable under storage (room temperature,
humidity, and light) conditions.2.3. Preparation of (PhSe)2 solution
The compound was dissolved in canola oil, and the desired
concentrations of (PhSe)2 were analyzed and prepared prior to
use. The solutions were stored at 2–8 °C and allowed to warm to
room temperature before use. The adult rats were given a single i.
p. injection of 10, 50, or 100 mg/kg (PhSe)2. The dosages of
(PhSe)2that were used in thepresent study were within the ther-
apeutic range (Nogueira and Rocha, 2011) because (PhSe)2 causes
neurotoxicity at very high doses.
2.4. Apparatus
Contextual fear conditioning occurred in four observation
chambers (252020 cm3). Each observation chamber was
placed inside a sound-attenuating box. A red light bulb (25 W) was
placed inside the box, and a video camera was mounted to the
back of the observation chamber so the animal's behavior could be
observed on a monitor outside the experimental chamber. The
ﬂoor of each observation chamber was composed of 15 stainless-
steel rods (4 mm diameter) spaced 1.5 cm center-to-center, which
were wired to a shock generator and scrambler (AVS, SCR04; São
Paulo, Brazil). An interface with eight channels (Insight, Ribeirão
Preto, Brazil) connected the shock generator to a computer, which
allowed the experimenter to apply an electric footshock. A digital
multimeter was used to calibrate the shock intensities before each
experiment. An ammonium hydroxide solution (5%) was used to
clean the chamber before and after each test.
2.5. Procedure
During the acquisition phase, each animal was placed in the
observation chamber for 8 min. At the end of this period, three
0.6 mA unsignaled electric footshocks were delivered (1 s dura-
tion, 20 s intershock interval). The animals were then returned to
their home cage 3 min after the last shock. The next day, the an-
imals were returned to the same chamber for 8 min with no
footshock or other stimulation during this period for the pheno-
typing test session. A time-sampling procedure was used to assess
fear conditioning in response to contextual cues. Every 2 s, the
animal was observed, and a well-trained observer recorded epi-
sodes of freezing, which were deﬁned as the total absence of
movement of the body or vibrissa, with the exception of move-
ment required for respiration. One week after this initial test
session of contextual aversive conditioning (phenotyping), CHF
and CLF rats were tested again in the same observation chamber.
Thirty minutes before the test, four independent groups of CHF
rats and four independent groups of CLF rats were in-
traperitoneally injected with either (PhSe)2 at three different
concentrations (10, 50, and 100 mg/kg) or vehicle. After the in-
jections,all of the rats were returned to their home cages where
they remained before the behavioral test session. The same time-
sampling procedure described above was used to record freezing
behavior during the 8 min test session.3. Results
Fig. 1 shows the mean and standard error of the mean (SEM)
percentage of time spent freezing in CHF and CLF animals of the
17th generation during the contextual fear conditioning test ses-
sion. As expected, CHF animals froze more that CLF animals. This
difference was conﬁrmed statistically. Student's t-test revealed a
signiﬁcant difference between CHF and CLF animals (t70¼12.50,
po0.001).















Fig. 1. Mean (7SEM) percentage of freezing in 17th-generation CHF and CLF rats
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Fig. 2. Mean (7SEM) percentage of freezing in CHF and CLF animals (n¼10 per
group) injected with either vehicle or (PhSe)2 at doses of 10, 50,and 100 mg/kg.
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(PhSe)2 at doses of 10, 50, or 100 mg/kg. The results were statis-
tically analyzed using two-way analysis of variance (ANOVA). The
ﬁrst factor, with two levels, was related to the breeding line (CHF
and CLF). The second factor, with four levels, was related to the
(PhSe)2 dose (vehicle, 10, 50, or 100 mg/kg). The analysis revealed
a main effect of breeding line (F1,72¼9.05, po0.005) and (PhSe)2
dose (F3,72¼11.61, po0.001). An interaction between breeding line
and (PhSe)2 dose (F3,72¼6.31, po0.01) was also detected. Pairwise
post hoc comparisons indicated that CHF animals that received
50 mg/kg (PhSe)2 exhibited less reliable conditioned freezing
compared with CHF animals that received vehicle (po 0.05). The
CHF animals that received 50 mg/kg (PhSe)2 exhibited consistently
more conditioned freezing compared with CLF animals that also
received 50 mg/kg (PhSe)2(po0.05). Pairwise post hoc compar-
isons indicated that CLF animals that received either 50 or 100 mg/
kg (PhSe)2 exhibited signiﬁcantly more conditioned freezing
compared with CLF animals that received vehicle (both po0.01).4. Discussion
In the present study, (PhSe)2 was administered at three doses
(10, 50, and 100 mg/kg) 30 min before measuring freezing patterns
in CHF and CLF animals. The choice of dose and time was based on
previous reports that showed that the maximal pharmacological
effects of (PhSe)2 can be achieved after 30 min in depression-like,
inﬂammation, and antinociception models (Savegnago et al.,
2007a, 2007b). Marina et al. provided baseline pharmacokinetic
data for (PhSe)2 and its absorption proﬁle in plasma. They showed
that the maximum concentration (Cmax) was achieved 30 min afteroral administration. The Cmax could be responsible for the ob-
served pharmacological and toxicological effects of (PhSe)2in acute
experimental models (Prigol et al., 2009).
Interestingly, both dose- and line-dependent effects were ob-
served for (PhSe)2. Fig. 2 shows that (PhSe)2 at 10 and 50 mg/kg
reduced freezing (i.e., an anxiolytic-like effect) in CHF rats. Our
results are consistent with Savegnago et al. (2007a, 2007b),who
showed that (PhSe)2 produced signiﬁcant antidepressant- and
anxiolytic-like effects in mice 30 min after oral administration.
Systemic (PhSe)2 administration exerted an anxiolytic-like effect
in rats, with no adverse effects on locomotion or exploratory ac-
tivity (Nogueira and Rocha, 2011). Regarding the possible me-
chanism of the anxiolytic-like effect of (PhSe)2, anxiety is very
complex and has no known deﬁnitive neurobiological or neuro-
chemical mechanism. However, the dysregulation of multiple re-
ceptor systems, such as γ-aminobutyric acid (GABA), N-methyl-D-
aspartate, dopamine D2 receptors, and 5-hydroxytryptamine (5-
HT; serotonin), are reported to be responsible for the incidence or
progression of anxiety-related disorders (Porter et al., 1989; Mal-
izia et al., 1998; Goddard et al., 2001). Previous studies indicated
that (PhSe)2 can interact with or modulate different neuronal and
neurotransmitter systems, which may account for its possible
anxiolytic-like effects. The interactions between (PhSe)2 and other
organoselenides and GABAergic, serotonergic (5-HT1A, 5HT2A, and
5-HT2A/2C), noradrenergic (α1 and α2), and dopaminergic (D1, D2,
and D3) systems have been reported in detail. Depending on the
structure of organochalcogens and route of administration,the
possible inhibition of the L-arginine-nitric oxide-cyclic guanosine
monophosphate pathway and modulation of peroxisome pro-
liferator-activated receptorγ cannot be excluded in the observed
psychological effects of selenium compounds (Nogueira and Ro-
cha, 2011).
Our data indicate that at a higher dose (100 mg/kg), the com-
pound exerted signiﬁcant anxiogenic-like effects in both CHF and
CLF rats. Data regarding the neurotoxic effects of organochalco-
gens have been scarcely reported in the literature. Chronic ex-
posure to higher doses of (PhSe)2 caused central effects in the
brain, including seizures, in rodents (Nogueira and Rocha, 2011).
Modulation of the glutamatergic and GABAergic systems (No-
gueira and Rocha, 2011) has been reported to be partially re-
sponsible for its neurotoxic effects, in which seizures induced by
higher doses of (PhSe)2 were prevented by diazepam, pheno-
barbital, and muscimol (Nogueira and Rocha, 2011).
In strong contrast to the CHF line, (PhSe)2 (even at lower doses)
increased freezing behavior in CLF animals, thus demonstrating
both anxiolytic- and anxiogenic-like effects of this organoselenium
compound in a bidirectional line. Previous studies have described
various toxic effects of (PhSe)2, including the generation of free
radicals, oxidation of simple mono- or di-thiols, and inhibition of
various thiol-containing enzymes (Nogueira and Rocha, 2010).
However, no clear evidence has been provided in the literature
about the possible anxiogenic-like activity of (PhSe)2 at low doses.
Importantly, the present study was conducted in a bi-direc-
tional line that is being bredto modify the expression of genes that
underlie a particular phenotype. With regard to the genetic reg-
ulation of anxiety and related disorders, Hovatta et al. (2005) re-
ported that the expression of the glutathione reductase (GSR1) and
glyoxalase (Glo1) genes that are involved in antioxidative meta-
bolism are highly correlated with anxiety-related phenotypes. The
expression of these enzymes was higher in the most “anxious”
mice and lower in the least “anxious” strains. However, several
contradictory reports have also been published. To further explore
the mechanism of anxiety regulation, Hambsch et al. (2010) and
Distler et al. (2012) reported that methylglyoxal (MG), the sub-
strate for GLO1, is responsible for the regulation of anxiety. The
neuroendocrine, neurochemical, and neurogenetic proﬁles of the
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studies could lead to possible diagnostic and therapeutic inter-
ventions. The possible role of GLO1 and MG in the CHF and CLF
phenotypes should be considered. The distinct genetic proﬁles of
the CHF and CLF lines may inﬂuence biochemical function, which
may lead to differential responses to different aversive situations
and various drugs. CHF and CLF animals exhibit different genetic
and neuronal vulnerability to different stressful situations, re-
ﬂected by differences in freezing responses, and may respond
differently to the same drug at different doses.
In conclusion, the present results indicated quiet different
modulation of freezing behavior in CHF and CLF rat lines by DPDS.
Infact, DPDS increased signiﬁcantly the freezing in CLF and tended
to decrease in CHF rats. The exact mechanism of the present
ﬁndings is yet to be explored but involvement of the mono-
aminergic, noradrenergic, dopaminergic, serotonergic, GABAA and
5-HT receptors cannot be neglected under the possible pathways
or mechanism involved in the apparent activities of DPDS.Acknowledgments
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